US2018361169A1PendingUtilityA1

System and method for optogenetic therapy

Assignee: CIRCUIT THERAPEUTICS INCPriority: Nov 21, 2012Filed: Mar 5, 2018Published: Dec 20, 2018
Est. expiryNov 21, 2032(~6.3 yrs left)· nominal 20-yr term from priority
A61P 9/12A61M 25/0105A61N 2005/0665A61M 37/0015A61N 1/3605A61K 38/164A61K 41/0057A61N 1/0551A61N 5/062A61K 38/16A61M 2037/0061A61K 41/00A61M 2037/0023A61K 38/177A61N 5/0622A61N 2005/0651A61M 2205/50A61N 2005/0626A61K 48/0075A61K 38/168A61N 2005/063A61K 48/00A61M 5/20A61B 17/3403A61M 5/142A61M 25/0147A61B 17/00234A61N 1/36053A61N 2005/0653A61N 2005/0643A61N 5/0601A61B 2017/3413A61N 2005/0631A61M 2205/3576A61N 2005/0627A61N 2005/0612A61N 2005/067A61N 5/067
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Claims

exact text as granted — not AI-modified
1 . A system for creating a directed action potential in a targeted nerve comprising light sensitive protein and coupled to a spinal cord of a patient, comprising:
 a. an implantable optical applicator configured to engage the targeted nerve and to deliver light to the targeted nerve, the implantable optical applicator operatively coupled to a light source configured to deliver photons to the implantable optical applicator which may be emitted by the implantable optical applicator into the targeted nerve to cause a membrane polarization change in the targeted nerve;   b. an implantable electrical stimulation applicator configured to engage the targeted nerve, the implantable electrical stimulation applicator operatively coupled to a power source configured to deliver electrons to the implantable electrical stimulation applicator which may be emitted by the implantable electrical stimulation applicator into the targeted nerve to cause a membrane polarization change in the targeted nerve; and   c. a controller operatively coupled to the light source and the power source and configured to cause both current to flow to the implantable electrical stimulation applicator and photons to be directed to the implantable optical applicator, such that an action potential is created which propagates in a first desired direction along the nerve, and which does not substantially propagate in a reverse direction along the nerve.

Join the waitlist — get patent alerts

Track US2018361169A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.